Viatris (VTRS) Other financing activities (2020 - 2026)
Viatris (VTRS) posted Other financing activities of -$24.5 million for Q2 2026, down 8066.67% on a QoQ basis from -$300000.0 in Q1 2026, and up 46.04% year-over-year from -$16.8 million in Q2 2025.
Analysis
Viatris (VTRS) Other financing activities (2020 - 2026) Analysis & Trends
Viatris has reported Other financing activities for 7 years, with the latest figure at -$24.5 million in Q2 2026.
- On a quarterly basis, Other financing activities rose 46.04% year-over-year to -$24.5 million in Q2 2026; TTM through Jun 2026 was -$59.9 million, a 625.44% decrease from a year earlier, with the FY2025 full-year figure at -$190.1 million, down 164.4% from the prior year.
- Other financing activities was -$24.5 million for Q2 2026 at Viatris, down from -$300000.0 in the prior quarter.
- The five-year high for Other financing activities was $122.6 million in Q2 2024, with the low at -$277.2 million in Q4 2023.
- Average Other financing activities over 5 years is -$4.1 million, with a median of $650000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Other financing activities jumped 23666.67% in 2023, then sank 1867.74% in 2025.
- Over 5 years, Other financing activities stood at $17.0 million in 2022, then slumped by 1730.59% to -$277.2 million in 2023, then soared by 135.46% to $98.3 million in 2024, then tumbled by 112.21% to -$12.0 million in 2025, then sank by 104.17% to -$24.5 million in 2026.
- The last three Other financing activities figures came in at -$24.5 million (Q2 2026), -$300000.0 (Q1 2026), and -$12.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.50 Mn |
| Mar 31, 2026 | -300,000.00 |
| Dec 31, 2025 | -12.00 Mn |
| Sep 30, 2025 | -23.10 Mn |
| Jun 30, 2025 | -45.40 Mn |
| Mar 31, 2025 | -109.60 Mn |
| Dec 31, 2024 | 98.30 Mn |
| Sep 30, 2024 | 68.10 Mn |
| Jun 30, 2024 | 122.60 Mn |
| Mar 31, 2024 | 6.20 Mn |
| Dec 31, 2023 | -277.20 Mn |
| Sep 30, 2023 | 71.30 Mn |
| Jun 30, 2023 | 21.10 Mn |
| Mar 31, 2023 | 11.80 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 9.60 Mn |